LifeStance Health Group, Inc. (LFST) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.82M; Additional Paid in Capital, Common StockUSD $2.24B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.88M; Additional Paid in Capital, Common StockUSD $2.27B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.88M; Additional Paid in Capital, Common StockUSD $2.33B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.89M; Additional Paid in Capital, Common StockUSD $2.31B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00.
LifeStance Health Group, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $3.82M | $2.24B | (m) | $-770.77M | $1.48B | $1.48B | 3 month · $19.75M 6 month · $34.95M |
| 2026-03-31 | $0.00 | $3.88M | $2.27B | (m) | $-794.38M | $1.48B | $1.48B | 3 month · $15.20M |
| 2025-12-31 | $0.00 | $3.88M | $2.33B | $0.00 | $-808.63M | $1.52B | $1.52B | 12 month · $74.70M |
| 2025-09-30 | $0.00 | $3.89M | $2.31B | $0.00 | $-820.29M | $1.49B | $1.49B | 3 month · $18.30M 9 month · $58.00M |
| 2025-06-30 | $0.00 | $3.89M | $2.29B | $345.00K | $-821.37M | $1.47B | $1.47B | 3 month · $21.12M 6 month · $39.70M |
| 2025-03-31 | $0.00 | $3.89M | $2.27B | $612.00K | $-817.58M | $1.46B | $1.46B | 3 month · $18.58M |
| 2024-12-31 | $0.00 | $3.83M | $2.26B | $929.00K | $-818.29M | $1.45B | $1.45B | 12 month · $76.17M |
| 2024-09-30 | $0.00 | $3.83M | $2.24B | $771.00K | $-811.18M | $1.44B | $1.44B | 3 month · $14.89M 9 month · $60.03M |
| 2024-06-30 | $0.00 | $3.83M | $2.23B | $2.64M | $-805.22M | $1.43B | $1.43B | 3 month · $24.55M 6 month · $45.13M |
| 2024-03-31 | $0.00 | $3.82M | $2.20B | $2.89M | $-781.94M | $1.43B | $1.43B | 3 month · $20.58M |
| 2023-12-31 | $0.00 | $3.79M | $2.18B | $2.30M | $-760.85M | $1.43B | $1.43B | 12 month · $102.79M |
| 2023-09-30 | $0.00 | $3.79M | $2.16B | $4.38M | $-715.89M | $1.46B | $1.46B | 3 month · $21.52M 9 month · $81.87M |
| 2023-06-30 | $0.00 | $3.78M | $2.14B | $4.15M | $-654.30M | $1.49B | $1.49B | 3 month · $33.11M 6 month · $60.34M |
| 2023-03-31 | $0.00 | $3.77M | $2.11B | $2.00M | $-608.83M | $1.51B | $1.51B | 3 month · $27.23M |
| 2022-12-31 | $0.00 | $3.76M | $2.08B | $3.27M | $-572.64M | $1.52B | $1.52B | 12 month · $188.79M |
| 2022-09-30 | $0.00 | $3.76M | $2.05B | $3.19M | $-525.98M | $1.53B | $1.53B | 3 month · $35.73M 9 month · $153.28M |
| 2022-06-30 | $0.00 | $3.76M | $2.02B | (m) | $-488.13M | $1.53B | $1.53B | 3 month · $57.51M 6 month · $117.55M |
| 2022-03-31 | $0.00 | $3.74M | $1.96B | (m) | $-419.40M | $1.54B | $1.54B | 3 month · $60.04M |
| 2021-12-31 | $0.00 | $3.74M | $1.90B | $0.00 | $-357.07M | $1.55B | $1.55B | 12 month · $259.44M |
| 2021-09-30 | (m) | $3.74M | $1.79B | (m) | $-249.04M | $1.54B | $1.54B | 3 month · $120.69M 9 month · $150.81M |
| 2021-06-30 | (m) | $3.74M | $1.67B | (m) | $-128.59M | $1.54B | $1.54B | 3 month · $29.52M 6 month · $30.12M |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $954.01M | 3 month · $605.00K |
| 2020-12-31 | $0.00 | $0.00 | $1.45M | (m) | $-13.12M | $997.84M | $997.84M | 9 month · $1.45M |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $999.65M | 3 month · $573.00K 6 month · $865.00K |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | $981.37M | 3 month · $292.00K |
| 2020-05-14 | (m) | (m) | (m) | (m) | (m) | (m) | $-464.38M | (m) |
| 2020-04-13 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-164.20M | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-166.35M | 12 month · $54.00K |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-109.10M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |